755
Participants
Start Date
February 27, 2020
Primary Completion Date
April 15, 2024
Study Completion Date
September 17, 2026
Belzutifan
Oral tablets
Everolimus
Oral tablets
Chang Gung Medical Foundation-Linkou Branch-Urology ( Site 1106), Taoyuan District
National Cheng Kung University Hospital ( Site 1103), Tainan City
Semmelweis Egyetem ( Site 0501), Budapest
Orszagos Onkologiai Intezet ( Site 0503), Budapest
Akershus universitetssykehus ( Site 0851), Lorenskog
Herlev Hospital ( Site 0251), Herlev
Borsod-Abaúj-Zemplén Megyei Központi Kórház és Egyetemi Okta-Klinikai Onkológiai és Sugárterápiás Ce, Miskolc
Debreceni Egyetem Klinikai Kozpont ( Site 0504), Debrecen
Helse Bergen HF - Haukeland Universitetssykehus ( Site 0854), Bergen
Aarhus University Hospital Skejby ( Site 0250), Aarhus
Zala Megyei Szent Rafael Korhaz ( Site 0509), Zalaegerszeg
National Taiwan University Hospital ( Site 1100), Taipei
Universitaetsmedizin Berlin ( Site 0400), Berlin
National Cancer Center ( Site 1204), Gyeonggi-do
Taipei Veterans General Hospital ( Site 1101), Taipei
Centre Francois Baclesse ( Site 0360), Caen
University of Rochester Medical Center ( Site 1543), Rochester
Abramson Cancer Center ( Site 1525), Philadelphia
Fox Chase Cancer Center ( Site 1506), Philadelphia
Sibley Memorial Hospital ( Site 1559), Washington D.C.
Istituto Nazionale dei Tumori ( Site 0601), Milan
Universitatsklinikum Hamburg-Eppendorf ( Site 0408), Hamburg
TYKS T-sairaala Syopatautien pkl ( Site 0301), Turku
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ( Site 1514), Baltimore
Trakya University Medical Faculty Balkan Oncology Hospital ( Site 1302), Edirne
CHU Besancon - Hopital Jean Minjoz ( Site 0351), Besançon
Fondazione Salvatore Maugeri clinica del lavoro ( Site 0600), Pavia
University of North Carolina at Chapel Hill ( Site 1537), Chapel Hill
Hospital Ramon y Cajal ( Site 1253), Madrid
Hospital General Universitario 12 de Octubre ( Site 1252), Madrid
Medical University of South Carolina ( Site 1518), Charleston
Institut de Cancerologie du Gard - CHU Caremeau ( Site 0352), Nîmes
Northwest Georgia Oncology Centers PC ( Site 1520), Marietta
CHU de Bordeaux Hop St ANDRE ( Site 0359), Bordeaux
Tampereen yliopistollinen sairaala ( Site 0300), Tampere
Istanbul Universitesi Cerrahpasa Tip Fakultesi ( Site 1305), Istanbul
Göztepe Prof. Dr. Süleyman Yalçın Şehir Hastanesi-oncology ( Site 1303), Istanbul
Chungnam National University Hospital ( Site 1205), Daejeon
Ege Universitesi Tip Fakultesi Hastanesi ( Site 1304), Izmir
Istituto Oncologico Veneto IRCCS ( Site 0603), Padua
University of Alabama - Birmingham ( Site 1538), Birmingham
Izmir Katip Celebi Universitesi Ataturk Egitim ve Arastirma Hastanesi ( Site 1306), Izmir
Azienda Ospedaliera Universitaria Integrata Verona - Ospedale Borgo Trento-Oncology Unit ( Site 0605, Verona
Henry Joyce Cancer Clinic ( Site 1544), Nashville
Universitaetsklinikum Magdeburg A.o.R. ( Site 0404), Magdeburg
Hattiesburg Clinic ( Site 1509), Hattiesburg
Policlinico S. Orsola-Malpighi ( Site 0606), Bologna
Universitaetsklinikum Duesseldorf ( Site 0410), Düsseldorf
Taichung Veterans General Hospital ( Site 1105), Taichung
Azienda Ospedaliero Universitaria di Modena Policlinico ( Site 0604), Modena
Cleveland Clinic ( Site 1504), Cleveland
Universitaetsklinikum Essen ( Site 0401), Essen
Oncology Hematology Care, Inc. ( Site 1524), Cincinnati
Instituto Valenciano de Oncologia - IVO ( Site 1254), Valencia
Henry Ford Cancer Center ( Site 1511), Detroit
MI Dnipr Regional Clinical Hospital named after I.I. Mechnikov ( Site 1453), Dnipropetrovsk
Medical Oncology Ospedale San Donato ( Site 0609), Arezzo
Centre Alexis Vautrin Institut de Cancerologie de Lorraine ( Site 0356), Vandœuvre-lès-Nancy
St. Vincent Frontier Cancer Center ( Site 1549), Billings
The University of Chicago Medical Center ( Site 1539), Chicago
Institut de cancérologie Strasbourg Europe (ICANS) ( Site 0350), Strasbourg
Centre Hospitalier Lyon Sud ( Site 0354), Pierre-Bénite
Ochsner Medical Center ( Site 1522), New Orleans
Azienda Ospedaliera Policlinico di Bari ( Site 0610), Bari
Kuopion Yliopistollinen Sairaala ( Site 0304), Kuopio
Universitaetsklinik fuer Urologie ( Site 0405), Tübingen
Oklahoma Cancer Specialists and Research Institute, LLC ( Site 1523), Tulsa
Texas Oncology, P.A.-Dallas ( Site 1534), Dallas
MI Precarpathian Clinical Oncology Center ( Site 1452), Ivano-Frankivsk
Texas Oncology-Austin Central ( Site 1533), Austin
University Of Colorado ( Site 1540), Aurora
UCHealth Highlands Ranch Hospital ( Site 1560), Highlands Ranch
Chang Gung Medical Foundation - Kaohsiung ( Site 1104), Kaohsiung City
Gustave Roussy ( Site 0353), Villejuif
St Joseph Heritage Healthcare ( Site 1531), Santa Rosa
Oregon Health & Science University ( Site 1553), Portland
SBIH City clinical hospital named after D.D. Pletniov ( Site 1160), Moscow
Administradora Country SA - Clinica del Country ( Site 1701), Bogotá
Clinica Colsanitas S.A. Sede Clinica Universitaria Colombia ( Site 1702), Bogota
N.N. Blokhin NMRCO ( Site 1156), Moscow
Russian Scientific Center of Roentgenoradiology ( Site 1155), Moscow
First Moscow State Medical University n.a. I.M.Sechenov ( Site 1163), Moscow
Hadassah Medical-Oncology department ( Site 1164), Moscow
Central Clinical Hospital with Polyclinic ( Site 1157), Moscow
Russian Scientific Center of Radiology and Surgical Technologies ( Site 1153), Saint Petersburg
SBHI SPb Clinical Research Centre of specialized types of medical care ( Site 1159), Saint Petersburg
City clinical oncological dispensary ( Site 1154), Saint Petersburg
Sociedad de Oncología Y Hematología del Cesar S.A.S. ( Site 1709), Valledupar
Omsk Clinical Oncology Dispensary ( Site 1150), Omsk
Oncologos del Occidente S.A. ( Site 1708), Pereira
Krasnoyarsk Regional Clinical Oncological Dispensary ( Site 1151), Krasnoyarsk
Bradfordhill ( Site 0003), Santiago
University of California San Diego Moores Cancer Center ( Site 1546), La Jolla
Massachusetts General Hospital ( Site 1558), Boston
Beth Israel Deaconess Medical Center ( Site 1501), Boston
Dana Farber Cancer Institute ( Site 1505), Boston
John Theurer Cancer Center at Hackensack University Medical Center ( Site 1513), Hackensack
Centro Avancado de Tratamento Oncologico ( Site 1657), Belo Horizonte
Instituto de Cancer e Transplante de Curitiba ICTR ( Site 1650), Curitiba
Liga Norte Riograndense Contra o Cancer ( Site 1651), Natal
Hospital de Clinicas de Porto Alegre ( Site 1655), Porto Alegre
Real e Benemerita Associacao Portuguesa de Beneficencia ( Site 1653), São Paulo
BC Cancer - Vancouver Center ( Site 0155), Vancouver
Nova Scotia Health Authority QEII-HSC ( Site 0150), Halifax
Juravinski Cancer Centre ( Site 0154), Hamilton
Sunnybrook Research Institute ( Site 0153), Toronto
Centre Hospitalier de l Universite de Montreal - CHUM ( Site 0151), Montreal
CHUQ-Univ Laval-Hotel Dieu de Quebec ( Site 0152), Québec
Centro Investigación del Cáncer James Lind ( Site 0004), Temuco
Fundacion Centro de Investigacion Clinica CIC ( Site 1703), Medellín
Masarykuv onkologicky ustav ( Site 0105), Brno
Fakultni nemocnice Ostrava ( Site 0103), Ostrava
Fakultni nemocnice Hradec Kralove ( Site 0106), Hradec Králové
Fakultni nemocnice Olomouc ( Site 0104), Olomouc
Fakultni nemocnice Kralovske Vinohrady ( Site 0102), Prague
Fakultni Thomayerova nemocnice ( Site 0107), Prague
HYKS. ( Site 0302), Helsinki
Universitaetsklinikum Carl Gustav Carus Dresden ( Site 0403), Dresden
Universitaetsklinikum Jena ( Site 0402), Jena
Prince of Wales Hospital ( Site 1050), Hong Kong
Queen Mary Hospital ( Site 1051), Hong Kong
Queen Elizabeth Hospital. ( Site 1052), Kowloon
Princess Margaret Hospital. ( Site 1053), Lai Chi Kok
Bekes Megyei Kozponti Korhaz - Pandy Kalman Tagkorhaza ( Site 0505), Gyula
Fondazione Policlinico Universitario A. Gemelli ( Site 0607), Roma
Azienda Ospedaliera Santa Maria ( Site 0602), Terni
Fujita Health University ( Site 1016), Toyoake
National Cancer Center Hospital East ( Site 1001), Kashiwa
Ehime University Hospital ( Site 1014), Tōon
Sapporo Medical University Hospital ( Site 1008), Sapporo
Yokohama City University Hospital ( Site 1015), Yokohama
Kanagawa cancer center ( Site 1021), Yokohama
Nara Medical University Hospital ( Site 1009), Kashihara
Kindai University Hospital- Osakasayama Campus-Urology ( Site 1011), Sayama
Osaka University Hospital ( Site 1006), Suita
Saitama Medical University International Medical Center ( Site 1012), Hidaka
Hamamatsu University Hospital ( Site 1005), Hamamatsu
Toyama University Hospital ( Site 1013), Toyoma
Yamaguchi University Hospital ( Site 1018), Ube
Kyushu University Hospital ( Site 1007), Fukuoka
Hiroshima University Hospital-Hiroshima University Hospital ( Site 1019), Hiroshima
Niigata University Medical & Dental Hospital ( Site 1022), Niigata
Okayama University Hospital ( Site 1020), Okayama
Tokushima University Hospital-Department of Urology ( Site 1017), Tokushima
National Cancer Center Hospital ( Site 1003), Tokyo
Toranomon Hospital ( Site 1004), Tokyo
Nippon Medical School Hospital ( Site 1010), Tokyo
The Cancer Institute Hospital of JFCR ( Site 1000), Tokyo
Keio University Hospital ( Site 1002), Tokyo
Korea University Anam Hospital ( Site 1203), Seoul
Severance Hospital Yonsei University Health System ( Site 1202), Seoul
Asan Medical Center ( Site 1200), Seoul
Samsung Medical Center ( Site 1201), Seoul
Instituto Catalan de Oncologia - ICO ( Site 1251), L'Hospitalet de Llobregat
Hospital Universitari Vall d Hebron ( Site 1250), Barcelona
Laenssjukhuset Ryhov ( Site 1853), Jönköping
Malmo Universitetssjukhus ( Site 1851), Malmo
Karolinska Universitetssjukhuset Solna ( Site 1850), Stockholm
Norrlands Universitetssjukhus ( Site 1856), Umeå
Ankara Universitesi Tip Fakultesi ( Site 1311), Ankara
Hacettepe Universitesi Tip Fakultesi ( Site 1300), Ankara
Gazi Universitesi Tip Fakultesi ( Site 1308), Ankara
Kyiv City Clinical Oncology Center ( Site 1450), Kyiv
Cambridge University Hospitals NHSFT ( Site 1405), Cambridge
Western General Hospital ( Site 1400), Edinburgh
The Beatson West of Scotland Cancer Centre ( Site 1402), Glasgow
Barts Health NHS Trust ( Site 1407), London
Royal Marsden NHS Foundation Trust ( Site 1403), London
Imperial Healthcare NHS Trust Charing Cross Hospital ( Site 1409), London
Royal Marsden Hospital Sutton-Surrey ( Site 1411), Sutton
Medway Maritime Hospital ( Site 1406), Gillingham
The Christie NHS Foundation Trust ( Site 1401), Manchester
Merck Sharp & Dohme LLC
INDUSTRY